Task: Answer the multiple-choice question.
Question: Which drug exhibits a 3.449\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CC(=O)c1ccc(-n2nnnc2SCC(=O)NNC(=O)c2ccco2)cc1
b. O=C(Nc1ccc(N2CCOCC2)cc1)c1nc2ccccc2s1
c. Cc1ccc(SCC(=O)O/N=C(\N)c2ccc([N+](=O)[O-])cc2)cc1
Answer: b. O=C(Nc1ccc(N2CCOCC2)cc1)c1nc2ccccc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N-(4-morpholin-4-ylphenyl)-1,3-benzothiazole-2-carboxamide